Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Clinical & experimental allergy 25 (1995), S. 0 
    ISSN: 1365-2222
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Clinical & experimental allergy 22 (1992), S. 0 
    ISSN: 1365-2222
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: The IgE-dependent activation of mononuclear phagocytic cells through their capacity to express low affinity IgE receptors (FcεRII) has been proposed as a mechanism for the development of airways inflammation in allergic asthma. This FcεRII expression leads to the IgE-dependent production of the potent pro-inflammatory cytokines IL-1β and TNF-α. Expression by monocytes of FcεRII is regulated by several cytokines including interleukin-4, γ- and α-interferons, and granulocyte-macrophage and macrophage colony stimulating factors. An anti-inflammatory effect of nedocromil on monocytes has been proposed as a possible mechanism for its anti-asthma activity. We therefore investigated the capacity of nedocromil to modulate mononuclear phagocyte FcεRII expression and cytokine production. We used an anti-FcεRII antibody and flow cytometric analysis to assess the capacity of nedocromil to modulate cytokine-induced FcεRII expression in normals and asthmatics. Monocytes, THP-1 monocyte leukaemia cells, and alveolar macrophages were exposed to varying concentrations of these cytokines for 48 hr at 37°C with or without the additional presence of nedocromil (1–10 μm) and the per cent of monocytes expressing FcεRII was determined. No changes in FcεRII expression were observed. Subsequently, we investigated the capacity of nedocromil to affect the capacity of IgE plus anti-IgE complexes, allergen, and LPS (16 hr/37°C) to stimulate IL-1β and IL-6 production. No changes were observed when nedocromil was applied concomitant with the stimulus. However, pre-treatment (30 min) with nedocromil was associated with a 59.5±5.6% inhibition of IL-6 production stimulated by allergen and 34.5±5.1% by anti-IgE. In conclusion, nedocromil does not modulate mononuclear phagocytic cell FcεRII expression but does suppress IgE-dependent cytokine production. This may represent an important anti-inflammatory action of nedocromil in the treatment of reactive obstructive airways disease.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...